Working in collaboration with Dr Eric Glasgow of the Georgetown University Medical Center in Washington D.C., the two teams used zebrafish models to study the consequences of chromosome 6 deletion and showed that the deletion has an effect on specific cells in the hypothalamus that produce a hormone called oxytocin.
This explains why sufferers are often severely obese, find it difficult to control their appetites and are prone to mood swings and being withdrawn.
The study, published in the latest issue of the American Journal of Human Genetics represents an important step in our understanding of how the hypothalamus and oxytocin control appetite and behaviour. Dr Banka, who is also a Consultant Clinical Geneticist at Saint Mary’s Hospital, said: «This finding demonstrates the power of human genetic study of rare conditions.»
Although at an early stage, the researchers hope that the findings will help form part of a picture of how the hypothalamus works and may lead to new treatments in the future.
The paper, Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability was published in the American Journal of Human Genetics.
Source: http://www.manchester.ac.uk/discover/news/new-syndrome-which-causes-obesity-and-intellectual-disabil...
